CancerTYPE ID in the Clinic

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.
July 17, 2018

How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.

January 20, 2016

Do Therapeutic Agents Affect Healthy Stem Cells?

Dr Wainberg and Dr Gerson ponder and provide opinions on whether these investigational therapies also target healthy cells.